Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
146 studies found for:    Open Studies | "Aggression"
Show Display Options
Rank Status Study
21 Not yet recruiting Omega-3 Supplementation and Behavior Problems
Conditions: Aggression;   Antisocial Behavior;   Attention Problems;   Anxiety
Interventions: Dietary Supplement: Omega-3 supplemented drink;   Dietary Supplement: Smartfish
22 Not yet recruiting Smoking Influence on Apoptosis in Periodontitis
Conditions: Chronic Periodontitis;   Aggressive Periodontitis
Intervention:
23 Recruiting Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder
Conditions: Intermittent Explosive Disorder;   Childhood Aggression;   Oppositional Defiant Disorder;   Attention Deficit Disorder
Interventions: Behavioral: Parent Management Training;   Other: Placebo;   Drug: Intuniv
24 Recruiting Treatment of Children With Peer Related Aggressive Behavior (ScouT)
Condition: Oppositional Defiant Disorder
Interventions: Behavioral: Social Skills Training;   Behavioral: Treatment Program with techniques to activate resources
25 Unknown  Preventing Aggression In Veterans With Dementia (PAVED) - Telephone Sub-Study With Rural Veterans
Conditions: Dementia;   Pain
Intervention: Behavioral: Preventing Aggression in Veterans with Dementia (PAVeD)
26 Recruiting Antisocial Behavior on Healthcare Professionals in an Emergency Unit.
Condition: Rudeness/Incivility, Aggression or Violence Against Healthcare Workers in an Ophthalmic Emergencies Unit.
Intervention:
27 Recruiting Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression
Condition: Traumatic Brain Injury
Interventions: Drug: Buspirone;   Drug: Placebo
28 Unknown  Effect of Massage Therapy on Aggression in a Psychiatric Inpatient Unit
Condition: Acute Psychiatric Disorders
Intervention: Procedure: Massage therapy
29 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
30 Unknown  Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Quetiapine XR
31 Recruiting Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ELND005;   Drug: Placebo
32 Recruiting The Effects of Midazolam on the Quality of Postoperative Recovery
Conditions: Postoperative Period;   Anxiety;   Fatigue;   Depression;   Aggression
Interventions: Drug: Midazolam;   Drug: NaCl (sodium chloride) 0,9%
33 Unknown  Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Valproate;   Drug: Risperidone;   Drug: Placebo;   Drug: Stimulant medication;   Behavioral: Behavioral family counseling
34 Unknown  Chronic Presence of Epstein Barr Virus in Epithelial Cells From Gingiva is Associated With Periodontitis
Conditions: Chronic Periodontitis;   Aggressive Periodontitis;   Presence / Absence of EBV
Intervention: Procedure: dental root planing
35 Recruiting Nitro-oxidative Stress in Periodontitis
Conditions: Chronic Periodontitis;   Aggressive Periodontitis
Intervention:
36 Recruiting A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
Conditions: Advanced Solid Tumors;   Aggressive B-cell Lymphomas
Interventions: Biological: MEDI6469/tremelimumab;   Biological: MEDI6469/MEDI4736;   Biological: MEDI6469/rituximab;   Biological: MEDI6469
37 Recruiting OPTIMAL>60, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
Condition: CD20+ Aggressive B-Cell Lymphoma
Interventions: Drug: Conventional Vincristine;   Drug: Liposomal Vincristine;   Drug: Ricover-scheme rituximab;   Drug: optimised rituximab-schedule
38 Recruiting Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition: Deep Fibromatosis/Desmoid Tumor
Interventions: Drug: Sorafenib Tosylate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment
39 Recruiting Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer
Conditions: Symptomatic, Aggressive, Sporadic, Unresectable, Locally;   Advanced/Metastatic Medullary Thyroid Cancer (MTC)
Intervention: Drug: Vandetanib 300 mg
40 Recruiting Adapting Dialectical Behavior Therapy for Children in Residential Care
Condition: Emotion Regulation, Verbal Aggression, Physical Aggression, Irritability, Anger
Interventions: Behavioral: DBT for children;   Behavioral: Supportive-Educational therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years